article thumbnail

Paragonix Technologies Receives FDA Clearance for BAROguard™ Donor Lung Preservation System

Legacy MEDSearch

Paragonix Technologies , a leading organ transplant company, received US Food and Drug Administration (“FDA”) clearance for its next-generation donor lung preservation system, BAROguard. Under current clinical practice, donor lungs are preserved and transported in an inflated state from donor to recipient site.

FDA 52
article thumbnail

Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA

Legacy MEDSearch

Food and Drug Administration has granted the Connexus DDI “Breakthrough Device Designation”, which offers an expedited review process for transformative medical devices with the potential to treat irreversibly debilitating conditions. In addition to the funding, Paradromics announced that the U.S.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Readjusting the Life Sciences Industry’s Approach to Improving Adherence

PM360

To put this into perspective: if all of the patients were 100% adherent, then at most the brand would achieve 25% of the TRx volume that their sales team successfully had physicians write,” explains Josh Richardson, Chief Commercial Officer, Prescryptive Health. Eli Phillips, Jr.,

article thumbnail

MedWand Solutions Receives FDA 510k Clearance

Legacy MEDSearch

Food and Drug Administration (FDA) has granted 510(k) clearance to the MedWand,” shared MedWand CEO and Co-Founder, Robert Rose. “As MedWand Remote Clinic – Designed for remote / regional clinics, transport, and industrial application. Please contact MedWand Sales to request a complimentary quotation.

FDA 52
article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

Pharma 122
article thumbnail

Teva says medicines access at risk in Northern Ireland

pharmaphorum

The protocol is a special trading arrangement that allows goods to be transported across the Irish land border without the need for checks, in the same way as they did when the UK was part of the EU customs union. “The warning presented by Teva UK is stark,” according to Cameron.

Medicine 104